About LGMD2I Research Fund
LGMD2I Research Fund is a non-profit 501(c)3 organization whose mission is to expedite the development of a treatment and/or cure for limb girdle muscular dystrophy 2I (LGMD2I). To achieve this goal, they are building a comprehensive view of the entire LGMD2I research landscape, placing well-informed bets on where the most promising research is being done, and bringing a level of coordination and management to the scientific process. Limb-girdle muscular dystrophies (LGMD) are a group of rare progressive genetic disorders that are characterized by wasting (atrophy) and weakness of the voluntary muscles of the hip and shoulder areas (limb-girdle area). Muscle weakness and atrophy are progressive and may spread to affect other muscles of the body. Many different subtypes have been identified based upon abnormal changes (mutations) of certain genes. The various forms of LGMD may be inherited as autosomal dominant or recessive traits. Autosomal recessive LGMD is known as LGMD2 and has 17 subtypes (LGMDA-Q).